.Attribute Medication, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Perspective requires inclusion of patients with MASLD as well as size of liver outcomes in cardio-- kidney-- metabolic tests, when data propose mechanistically conceivable perks as well as scientific security-- and lays out factors to consider for trial style and also regulatory commendation.